Mercury Pharmaceuticals Limited

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

Address

Capital House, 1st Floor, 85 King William Street

London
EC4N 7B
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Mercury Pharmaceuticals Limited
Sign up free

Contracts awarded to Mercury Pharmaceuticals Limited

The contracts that Mercury Pharmaceuticals Limited have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 3 weeks ago

Branded and Biosimilar Ophthalmology

Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

£20,671,084
Award

Published 3 months ago

NP30925 Psychiatry and Neurology Medicines

Supply of psychiatry and neurology medicines to NHS Scotland.

£7,031,939
Award

Published 4 months ago

NHS National Generic Pharmaceuticals Wave 15b

NHS National Pharmaceuticals Generic Products – Wave 15b Offer reference number: CM/PHG/23/5698 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/23/5698/01 – Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months) NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months) LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months) CM/PHG/23/5698/02 – Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months) CM/PHG/23/5698/03 – Hospital Only (Housekeeping) Products DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months) DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months) DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)

£147
Award

Published 4 months ago

Gastrointestinal, Endocrine, Nutrition & Blood Medicines

This Framework Agreement is for the supply of Gastrointestinal, Endocrine, Nutrition & Blood Medicines to health boards across NHS Scotland. The Goods have been split into fourteen (14) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

£48,954,512
Award

Published 5 months ago

Generic Drugs – Topicals & Miscellaneous

Generic Drugs – Topicals & Miscellaneous

£10,482,625
Award

Published 7 months ago

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

Project title: NHS National Framework for the supply of Generics Housekeeping Products & Oral Products, commencing 1 June 2025 Offer reference number: CM/PHG/24/5720 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/24/5720/01 - Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st June 2025 to 31st May 2027 (24 months) NWLN: (Northwest and London North): 1st June 2025 to 31st May 2027 (24 months) LSNE: (London South and Northeast): 1st June 2025 to 31st May 2027 (24 months) CM/PHG/24/5720/02 - Hospital Only Products DCE (Midlands) & DSW (Southwest): 1st June 2025 to 31st May 2026 (12 months) DNW (Northwest) & DLN (London North): 1st June 2025 to 31st January 2027 (20 months) DLS (London South) & DNE (Northeast): 1st June 2025 to 31st May 2026 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

£11,656,086 Bids close: 10 months ago

Contacts

+44 2085889335

Statistics (1 Year)

Contracts Won

Total Won

£48,582,610

Average Win

£12,145,653

Mercury Pharmaceuticals Limited

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Mercury Pharmaceuticals Limited

Branded and Biosimilar Ophthalmology

NP30925 Psychiatry and Neurology Medicines

NHS National Generic Pharmaceuticals Wave 15b

Gastrointestinal, Endocrine, Nutrition & Blood Medicines

Generic Drugs – Topicals & Miscellaneous

NHS National Framework - Generics Housekeeping/Supply Chain Resilience Products

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win